{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:55:27Z","timestamp":1764251727587},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00059-021-05077-4","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T16:02:50Z","timestamp":1636473770000},"page":"520-525","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Non-transvenous ICD therapy: current status and beyond"],"prefix":"10.1007","volume":"46","author":[{"given":"Vincent F.","family":"van Dijk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas V. A.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,9]]},"reference":[{"issue":"24","key":"5077_CR1","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","volume":"21","author":"SJ Connolly","year":"2000","unstructured":"Connolly\u00a0SJ, Hallstrom\u00a0AP, Cappato\u00a0R et al (2000) meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac arrest study hamburg. Canadian implantable defibrillator study. Eur Heart\u00a0J 21(24):2071\u20132078","journal-title":"Eur Heart J"},{"issue":"12","key":"5077_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa013474","volume":"346","author":"AJ Moss","year":"2002","unstructured":"Moss\u00a0AJ, Zareba\u00a0W, Hall\u00a0WJ et\u00a0al (2002) Prophylactic implantation of a\u00a0defibrillator in patients with myocardial infarction and reduced ejection fraction. N\u00a0Engl J Med 346(12):877\u2013883","journal-title":"N Engl J Med"},{"issue":"41","key":"5077_CR3","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori\u00a0SG, Blomstrom-Lundqvist\u00a0C, Mazzanti\u00a0A et al (2015) 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the europe. Eur Heart\u00a0J 36(41):2793\u20132867","journal-title":"Eur Heart J"},{"issue":"10","key":"5077_CR4","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1016\/j.hrthm.2017.10.036","volume":"15","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib\u00a0SM, Stevenson\u00a0WG, Ackerman\u00a0MJ et al (2018) 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines and the heart rhythm society. Heart Rhythm 15(10):e73\u2013189","journal-title":"Heart Rhythm"},{"issue":"16","key":"5077_CR5","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.295.16.1901","volume":"295","author":"WH Maisel","year":"2006","unstructured":"Maisel\u00a0WH, Moynahan\u00a0M, Zuckerman\u00a0BD et\u00a0al (2006) Pacemaker and ICD generator malfunctions: analysis of food and drug administration annual reports. JAMA 295(16):1901\u20131906","journal-title":"JAMA"},{"issue":"6","key":"5077_CR6","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.amjcard.2012.11.052","volume":"111","author":"A Habib","year":"2013","unstructured":"Habib\u00a0A, Le\u00a0KY, Baddour\u00a0LM et\u00a0al (2013) Predictors of mortality in patients with cardiovascular implantable electronic device infections. Am J Cardiol 111(6):874\u2013879","journal-title":"Am J Cardiol"},{"issue":"1","key":"5077_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa0909545","volume":"363","author":"GH Bardy","year":"2010","unstructured":"Bardy\u00a0GH, Smith\u00a0WM, Hood\u00a0MA et al (2010) An entirely subcutaneous implantable cardioverter-defibrillator. N\u00a0Engl J Med 363(1):36\u201344","journal-title":"N Engl J Med"},{"issue":"6","key":"5077_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.tcm.2019.09.006","volume":"30","author":"VF van Dijk","year":"2020","unstructured":"van Dijk\u00a0VF, Boersma\u00a0LV (2020) The subcutaneous implantable cardioverter defibrillator in 2019 and beyond. Trends Cardiovasc Med 30(6):378\u2013384. https:\/\/doi.org\/10.1016\/j.tcm.2019.09.006","journal-title":"Trends Cardiovasc Med"},{"issue":"4","key":"5077_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/eurheartj\/ehv507","volume":"38","author":"CJ McLeod","year":"2017","unstructured":"McLeod\u00a0CJ, Boersma\u00a0L, Okamura\u00a0H, Friedman\u00a0PA (2017) The subcutaneous implantable cardioverter defibrillator: state-of-the-art review. Eur Heart\u00a0J 38(4):247\u2013257","journal-title":"Eur Heart J"},{"issue":"3","key":"5077_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.hrthm.2016.11.025","volume":"14","author":"LV Boersma","year":"2017","unstructured":"Boersma\u00a0LV, Barr\u00a0CS, Burke\u00a0MC et al (2017) Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a\u00a0primary prevention indication with and without a\u00a0reduced ejection fraction versus patients with a\u00a0secondary prevention indication. Heart Rhythm 14(3):367\u2013375","journal-title":"Heart Rhythm"},{"issue":"9","key":"5077_CR11","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","volume":"128","author":"R Weiss","year":"2013","unstructured":"Weiss\u00a0R, Knight\u00a0BP, Gold\u00a0MR et al (2013) Safety and efficacy of a\u00a0totally subcutaneous implantable-cardioverter defibrillator. Circulation 128(9):944\u2013953","journal-title":"Circulation"},{"issue":"7","key":"5077_CR12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/jce.13498","volume":"29","author":"ABE Quast","year":"2018","unstructured":"Quast\u00a0ABE, van Dijk\u00a0VF, Yap\u00a0SC et al (2018) Six-year follow-up of the initial Dutch subcutaneous implantable cardioverter-defibrillator cohort: long-term complications, replacements, and battery longevity. J\u00a0Cardiovasc Electrophysiol 29(7):1010\u20131016. https:\/\/doi.org\/10.1111\/jce.13498","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"12","key":"5077_CR13","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.jacep.2020.05.036","volume":"6","author":"MC Burke","year":"2020","unstructured":"Burke\u00a0MC, Aasbo\u00a0JD, El-Chami\u00a0MF et al (2020) 1\u2011year prospective evaluation of clinical outcomes and shocks: the subcutaneous ICD post approval study. JACC Clin Electrophysiol 6(12):1537\u20131550","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"5077_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.048728","volume":"143","author":"MR Gold","year":"2021","unstructured":"Gold\u00a0MR, Lambiase\u00a0PD, El-Chami\u00a0MF et al (2021) Primary results from the understanding outcomes with the S\u2011ICD in primary prevention patients with low ejection fraction (UNTOUCHED) trial. Circulation 143(1):7\u201317","journal-title":"Circulation"},{"issue":"6","key":"5077_CR15","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1056\/NEJMoa1915932","volume":"383","author":"RE Knops","year":"2020","unstructured":"Knops\u00a0RE, Olde Nordkamp\u00a0LRA, Delnoy\u00a0P\u2011PHM et al (2020) Subcutaneous or transvenous defibrillator therapy. N\u00a0Engl J Med 383(6):526\u2013536","journal-title":"N Engl J Med"},{"issue":"4","key":"5077_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/jce.12612","volume":"26","author":"AJ Brisben","year":"2015","unstructured":"Brisben\u00a0AJ, Burke\u00a0MC, Knight\u00a0BP et al (2015) A new algorithm to reduce inappropriate therapy in the S\u2011ICD system. J\u00a0Cardiovasc Electrophysiol 26(4):417\u2013423","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"5077_CR17","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.hrthm.2018.05.011","volume":"15","author":"DAMJ Theuns","year":"2018","unstructured":"Theuns\u00a0DAMJ, Brouwer\u00a0TF, Jones\u00a0PW et al (2018) Prospective blinded evaluation of a\u00a0novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm 15(10):1515\u20131522","journal-title":"Heart Rhythm"},{"issue":"24","key":"5077_CR18","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","volume":"367","author":"AJ Moss","year":"2012","unstructured":"Moss\u00a0AJ, Schuger\u00a0C, Beck\u00a0CA et\u00a0al (2012) Reduction in inappropriate therapy and mortality through ICD programming. N\u00a0Engl J Med 367(24):2275\u20132283","journal-title":"N Engl J Med"},{"issue":"1","key":"5077_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.joa.2015.12.001","volume":"32","author":"BL Wilkoff","year":"2016","unstructured":"Wilkoff\u00a0BL, Fauchier\u00a0L, Stiles\u00a0MK et al (2016) 2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. J\u00a0Arrhythmia 32(1):1\u201328","journal-title":"J Arrhythmia"},{"issue":"3","key":"5077_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.hrthm.2018.09.029","volume":"16","author":"A-FBE Quast","year":"2019","unstructured":"Quast\u00a0A\u2011FBE, Baalman\u00a0SWE, Brouwer\u00a0TF et al (2019) A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: the PRAETORIAN score. Heart Rhythm 16(3):403\u2013410","journal-title":"Heart Rhythm"},{"key":"5077_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ahj.2019.05.002","volume":"214","author":"A-FBE Quast","year":"2019","unstructured":"Quast\u00a0A\u2011FBE, Baalman\u00a0SWE, Betts\u00a0TR et al (2019) Rationale and design of the PRAETORIAN-DFT trial: a prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing. Am Heart\u00a0J 214:167\u2013174","journal-title":"Am Heart J"},{"key":"5077_CR22","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.jacc.2016.02.039","volume":"67","author":"FVY Tjong","year":"2016","unstructured":"Tjong\u00a0FVY, Brouwer\u00a0TF, Kooiman\u00a0KM et al (2016) Communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable defibrillator. J\u00a0Am Coll Cardiol 67:1865\u20131866","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"5077_CR23","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/europace\/euy019","volume":"20","author":"A-FBE Quast","year":"2018","unstructured":"Quast\u00a0A\u2011FBE, Tjong\u00a0FVY, Koop\u00a0BE et al (2018) Device orientation of a\u00a0leadless pacemaker and subcutaneous implantable cardioverter-defibrillator in canine and human subjects and the effect on intrabody communication. Europace 20(11):1866\u20131871","journal-title":"Europace"},{"issue":"13","key":"5077_CR24","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.jacep.2017.04.002","volume":"3","author":"FVY Tjong","year":"2017","unstructured":"Tjong\u00a0FVY, Brouwer\u00a0TF, Koop\u00a0B et al (2017) Acute and 3\u2011month performance of a\u00a0communicating leadless antitachycardia pacemaker and subcutaneous implantable defibrillator. JACC Clin Electrophysiol 3(13):1487\u20131498","journal-title":"JACC Clin Electrophysiol"},{"issue":"6","key":"5077_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.hrcr.2015.07.009","volume":"1","author":"B Mondesert","year":"2015","unstructured":"Mondesert\u00a0B, Dubuc\u00a0M, Khairy\u00a0P et al (2015) Combination of a\u00a0leadless pacemaker and subcutaneous defibrillator: first in-human report. HeartRhythm Case Rep 1(6):469\u2013471","journal-title":"HeartRhythm Case Rep"},{"issue":"11","key":"5077_CR26","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/europace\/euw337","volume":"19","author":"GL Botto","year":"2017","unstructured":"Botto\u00a0GL, Forleo\u00a0GB, Capucci\u00a0A et al (2017) The Italian subcutaneous implantable cardioverter-defibrillator survey: S\u2011ICD, why not? Europace 19(11):1826\u20131832","journal-title":"Europace"},{"issue":"5","key":"5077_CR27","first-page":"S200","volume":"4","author":"SK Tung","year":"2007","unstructured":"Tung\u00a0SK, Bennett\u00a0M, Yeung-Lai-Wah\u00a0JALH (2007) Minimal invasive extra cardiac placement of high voltage defibrillator leads. Heart Rhythm 4(5):S200","journal-title":"Heart Rhythm"},{"issue":"1","key":"5077_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.hrcr.2016.09.013","volume":"3","author":"RE Bhagwandien","year":"2016","unstructured":"Bhagwandien\u00a0RE, Kik\u00a0C, Yap\u00a0S\u2011C, Szili-Torok\u00a0T (2016) Substernal ICD lead implantation in a\u00a0patient not suitable for subcutaneous ICD implantation without venous access due to superior vena cava syndrome. HeartRhythm Case Rep 3(1):97\u201399","journal-title":"HeartRhythm Case Rep"},{"issue":"4","key":"5077_CR29","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.hrthm.2017.11.030","volume":"15","author":"DP Sholevar","year":"2018","unstructured":"Sholevar\u00a0DP, Tung\u00a0S, Kuriachan\u00a0V et\u00a0al (2018) Feasibility of extravascular pacing with a\u00a0novel substernal electrode configuration: the substernal pacing acute clinical evaluation study. Heart Rhythm 15(4):536\u2013542","journal-title":"Heart Rhythm"},{"issue":"8","key":"5077_CR30","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacep.2016.12.026","volume":"3","author":"JYS Chan","year":"2017","unstructured":"Chan\u00a0JYS, Lelakowski\u00a0J, Murgatroyd\u00a0FD et\u00a0al (2017) Novel extravascular defibrillation configuration with a\u00a0coil in the substernal space: the ASD clinical study. JACC Clin Electrophysiol 3(8):905\u2013910","journal-title":"JACC Clin Electrophysiol"},{"issue":"2","key":"5077_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jacep.2018.11.003","volume":"5","author":"LVA Boersma","year":"2019","unstructured":"Boersma\u00a0LVA, Merkely\u00a0B, Neuzil\u00a0P et\u00a0al (2019) Therapy from a\u00a0novel substernal lead: the ASD2 study. JACC Clin Electrophysiol 5(2):186\u2013196","journal-title":"JACC Clin Electrophysiol"},{"issue":"12","key":"5077_CR32","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.jacep.2020.05.029","volume":"6","author":"I Crozier","year":"2020","unstructured":"Crozier\u00a0I, Haqqani\u00a0H, Kotschet\u00a0E et al (2020) First-in-human chronic implant experience of the substernal extravascular implantable cardioverter-defibrillator. JACC Clin Electrophysiol 6(12):1525\u20131536","journal-title":"JACC Clin Electrophysiol"},{"issue":"7","key":"5077_CR33","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","volume":"70","author":"L Boersma","year":"2017","unstructured":"Boersma\u00a0L, Barr\u00a0C, Knops\u00a0R et al (2017) Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study. J\u00a0Am Coll Cardiol 70(7):830\u2013841","journal-title":"J Am Coll Cardiol"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-021-05077-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-021-05077-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-021-05077-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T21:03:57Z","timestamp":1638565437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-021-05077-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,9]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5077"],"URL":"https:\/\/doi.org\/10.1007\/s00059-021-05077-4","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,9]]},"assertion":[{"value":"7 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"L.V.\u00a0Boersma is a\u00a0consultant for Boston Scientific and Medtronic. V.F.\u00a0van Dijk is a\u00a0consultant for Boston scientific.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}